TPN Electrolytes is a Intravenous Injection, Solution, Concentrate in the Human Prescription Drug category. It is labeled and distributed by Hospira, Inc.. The primary component is Sodium Chloride; Calcium Chloride; Potassium Chloride; Magnesium Chloride; Sodium Acetate Anhydrous.
| Product ID | 0409-5779_9e425b07-c992-45e7-a04f-1e019a63b7a5 |
| NDC | 0409-5779 |
| Product Type | Human Prescription Drug |
| Proprietary Name | TPN Electrolytes |
| Generic Name | Sodium Chloride, Calcium Chloride, Potassium Chloride, Magnesium Chloride, And Sodium Acetate Anhydrous |
| Dosage Form | Injection, Solution, Concentrate |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2005-02-28 |
| Marketing Category | NDA / NDA |
| Application Number | NDA018895 |
| Labeler Name | Hospira, Inc. |
| Substance Name | SODIUM CHLORIDE; CALCIUM CHLORIDE; POTASSIUM CHLORIDE; MAGNESIUM CHLORIDE; SODIUM ACETATE ANHYDROUS |
| Active Ingredient Strength | 321 mg/20mL; mg/20mL; mg/20mL; mg/20mL; mg/20mL |
| Pharm Classes | Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Blood Coagulation Factor [EPC],Increased Coagulation Factor Activity [PE],Calcium [CS],Cations, Divalent [CS],Potassium Compounds [CS],Potassium Salt [EPC],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Calculi Dissolution Agent [EPC],Magnesium Ion Exchange Activity [MoA],Osmotic Laxative [EPC],Osmotic Activity [MoA],Inhibition Small Intestine Fluid/Electrolyte Absorption [PE],Increased Large Intestinal Motility [PE],Stimulation Large Intestine Fluid/Electrolyte Secretion [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2005-02-28 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA018895 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2018-04-05 |
| Marketing Category | NDA |
| Application Number | NDA018895 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2005-02-28 |
| Ingredient | Strength |
|---|---|
| SODIUM CHLORIDE | 321 mg/20mL |
| SPL SET ID: | c00817bc-7b62-4abe-0280-e7930eda3f94 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |